1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. CHEMOINFORMATICS MARKET BY TOOLS
5.1. Introduction
5.2. Solutions
5.3. Services
6. CHEMOINFORMATICS MARKET BY APPLICATION
6.1. Introduction
6.2. Drug Discovery
6.3. Clinical Research
6.4. Chemical Analysis
6.5. Others
7. CHEMOINFORMATICS MARKET BY END-USER
7.1. Introduction
7.2. Pharmaceuticals & Biotech Companies
7.3. Research & Academic Institutes
7.4. Others
8. CHEMOINFORMATICS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Agilent Technologies Inc.
10.2. Bio-Rad Laboratories Inc.
10.3. BioSolveIT GmbH
10.4. Dassault Systèmes
10.5. Certara
10.6. Jubilant Biosys Inc.
10.7. OpenEye Scientific (Cadence Design Systems)
10.8. Schrödinger Inc
10.9. Collaborative Drug Discovery Inc
10.10. Genedata (Danaher Corporation)
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES